FdaApplication
ANDA 206516
Identifiers
- fda_app_no: ANDA206516
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LLC |
| application_type | ANDA |
| approval_date | 2017-02-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOLEUCOVORIN CALCIUM | LEVOLEUCOVORIN CALCIUM | EQ 50MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product